SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?


To: RWReeves who wrote (1022)10/20/1999 10:56:00 PM
From: tom popeRead Replies (1) | Respond to of 4974
 
OT --- Re: Merrill Lynch

You cannot yet short from the internet platform, which, as I said, is rudimentary, nor will it keep your balances up to date during the day. But you always have the option of phone contact with your financial advisor. The expectation is that the internet platform will be more trading oriented as internet based trading is rolled out at the end of the year.

Executions are very good. I almost always use limit orders and have been surprised how often I get filled at the inside ask if I'm selling and vice versa.

I also use Schwab, and find that Schwab' executions can be very good as well, but when it's bad it's horrid. And the customer service guys at Schwab are pleasant and efficient if you're simply looking for information, but have been trained to stonewall (and in one case with me, lie) when a problem arises. With ML, the "financial advisor" at least provides a sympathetic ear. As a result I'm gradually winding down my Schwab accounts and might be interested in the Morgan Stanley/Discover offering if the fees were competitive.

BTW, the bulk of my trading is with MBT.



To: RWReeves who wrote (1022)10/20/1999 11:25:00 PM
From: Bob KimRespond to of 4974
 
$1500 flat per year

That's the minimum per year. As your asset level increases, the fee gradually increases.

There are a few drawbacks to the online research system. You don't get access to most of the time-sensitive stuff and when you do get access it is often well after CNBC has already reported it. The research part also goes down a lot.